Natco Pharma Limited CC-Sep23.pdf
15 Nov 2023
-
So, just last year, same quarter, was pure base business with out revenue and even without the aggregate scale-up and we had reported margins in the range of around 22%. So, is that the right way to look at the business ex-of revenue?
Read in transcript -
Just to -- what was the R&D number for 2Q, this year?
Read in transcript -
And that would be the same trend going ahead?
Read in transcript